Permissive role of adenosine A2A receptors on metabotropic glutamate receptor 5 (mGluR5)-mediated effects in the striatum

Journal of Neurochemistry

Volumn 90, Issue 5, 2004, Pages 1276-1279

  Domenici, M R ^a   Pepponi, R ^b   Martire, A ^b   Tebano, M T ^b   Potenza, R L ^b   Popoli, P ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b NONE

Author keywords

Adenosine A2A receptors; Corticostriatal slices; Metabotropic glutamate 5 (mGlu5) receptors; NMDA; Rat; Striatal neurons

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; KT 5720; LACTATE DEHYDROGENASE; METABOTROPIC RECEPTOR 5; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CORPUS STRIATUM; DRUG EFFECT; NERVE CELL CULTURE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ADENOSINE; ANIMALS; CARBAZOLES; CELLS, CULTURED; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROPHYSIOLOGY; EMBRYO; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLYCINE; INDOLES; MALE; MEMBRANE POTENTIALS; N-METHYLASPARTATE; PHENETHYLAMINES; PHENYLACETATES; PREGNANCY; PYRIDINES; PYRROLES; RATS; RATS, WISTAR; RECEPTORS, ADENOSINE A2; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, PURINERGIC P1; TRIAZINES; TRIAZOLES;

ANIMALIA;

EID: 4444382866     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02607.x     Document Type: Article

References (25)

1. Bruno V., Battaglia G., Copani A. et al. (2001) An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors. Eur. J. Neurosci. 13, 1469-1478.
2. Calabresi P., Centonze D., Pisani A. and Bernardi G. (1999) Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease. Exp. Neural. 158, 97-108.
3. 6- methyldeoxyadenosine is mediated through adenosine A2a receptors and via cAMP and MAPK signaling pathways. Biochem. Biophys. Res. Commun. 304, 795-800.
4. Chen J. F., Xu K., Petzer J. P., Staal R., Xu Y. H., Beilstein M., Sonsalla P. K., Castagnoli K., Castagnoli N. and Schwarzschild M. (2001) Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci. 21, RC 143, 1-6.
5. Cunha R. A. and Ribeiro J. A. (2000) Adenosine A2A receptor facilitation of synaptic transmission in the CA1 area of the rat hippocampus requires protein kinase C but not protein kinase A activation. Neurosci. Lett. 289, 127-130.
6. 2 receptors. Neurosci. Lett. 324, 154-158.
7. Domenici M. R., Pintor A., Potenza R. L., Gaudi S., Grò M. C., Passarelli F., Reggio R., Galluzzo M., Massotti M. and Popoli P. (2003) Metabotropic glutamate receptor 5 (mGluR5)-mediated phosphoinositide hydrolysis and NMDA-potentiating effects are blunted in the striatum of aged rats: a possible additional mechanism in striatal senescence. Eur J Neurosci. 17, 2047-2055.
8. 2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristic of dopamine D2 receptors in the striaturn. Neuropharmacol. 38, 129-140.
9. Ferré S., Karcz-Kubicha M., Hope B. T. et al. (2002) Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc. Natl Acad. Sci. USA 99, 11940-11945.
10. Fuxe K., Agnati L. F., Jacobson K. et al. (2003) Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease. Neurology 61, S19-S23.
11. Gubellini P., Saulle E., Centoze D., Bonsi P., Bernardi G., Conquet F. and Calabresi P. (2001) Selective involvement of mGlul receptors in corticostriatal LTD. Neuropharmacology 40, 839-846.
12. 14C]-2-deoxyglucose autoradiographic study. J. Neurosci. 17, 4415-4425.
13. Mao L. and Wang J. Q. (2003) Phosphorylation of cAMP response elementbinding protein in cultured striatal neurons by metabotropic glutamate receptor subtype 5. J. Neurochem. 84, 233-243.
14. 2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behaviour and ischemic brain damage induced by permanent focal ischemia in the rat. Brain Res. 959, 243-250.
15. Nishi A., Liu F., Matsuyama S., Hamada M., Higashi H., Nairn A. C. and Greengard P. (2003) Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling. Proc. Natl Acad. Sci. USA 100, 1322-1327.
16. Nörenberg W., Wirkner K., Aßmann H., Richter M. and Illes P. (1998) Adenosine A2A receptors inhibit the conductance of NMDA receptor channels in the rat neostriatal neurons. Amino Acids 14, 33-39.
17. Orlando L. R., Alsdorf S. A., Penney J. B. and Young A. B. (2001) The role of group I and group 11 metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity. Exp. Neurol. 167, 196-204.
18. 2A receptors. Neuroreport 11, 3611-3614.
19. Pisani A., Gubellini P., Bonsi P., Conquet F., Picconi B., Centonz D., Bernard G. and Calabresi P. (2001) Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny stnatal neurons. Neuroscience 106, 579-587.
20. 2A receptor stimulation enhances striatal extracellular glutamate levels in rats. Eur. J. Pharmacol. 287, 215-217.
21. 2 receptors in the rat striatum: interaction with adenosine A2A receptors. Neuropsychopharmacology 25, 505-513.
22. Popoli P., Pintor A., Domenici M. R. et al. (2002) Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acidinduced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum. J. Neurosci. 22, 1967-1975.
23. Sung K. W., Choi S. and Lovinger D. M. (2001) Activation of group I mGluRs is cnecessary for induction of long-term depression at striatal synapses. J. Neurophysiol. 86, 2405-2412.
24. Testa C. M., Standaert D. G., Landwehrmeyer G. B., Penney J. B. and Young A. B. (1995) Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurones. J. Comp. Neurol. 354, 241-252.
25. Ugolini A., Corsi M. and Bordi F. (1999) Potentiation of NMDA and AMPA responses by the specific mGluR5 agonist CHPG in spinal cord motoneurons. Neuropharmacology 38, 1569-1576.